| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BIOGEN INC | 38,000 | 11,982,000 | 5.59% | ||
| 2 | AMGEN INC | 82,500 | 9,766,000 | 4.56% | ||
| 3 | AMGEN INC | 82,500 | 9,766,000 | 4.56% | Put | |
| 4 | MEDTRONIC INC | 152,500 | 9,723,000 | 4.54% | ||
| 5 | CELGENE CORP | 105,000 | 9,017,000 | 4.21% | ||
| 6 | ISHARES TR | 75,000 | 8,911,000 | 4.16% | Put | |
| 7 | MERCK & CO INC | 147,500 | 8,533,000 | 3.98% | ||
| 8 | GILEAD SCIENCES INC | 75,000 | 6,219,000 | 2.90% | ||
| 9 | Mylan Inc | 105,000 | 5,414,000 | 2.53% | ||
| 10 | SPDR S&P 500 ETF TR PUT | 25,000 | 4,893,000 | 2.28% | Put | |
| 11 | ABBVIE INC | 85,000 | 4,797,000 | 2.24% | ||
| 12 | IONIS PHARMACEUTICAL | 135,000 | 4,651,000 | 2.17% | ||
| 13 | GW PHARMACEUTICALS PLC | 42,500 | 4,560,000 | 2.13% | ||
| 14 | HCA HOLDINGS INC | 80,000 | 4,511,000 | 2.10% | ||
| 15 | PERRIGO CO PLC | 30,000 | 4,373,000 | 2.04% | Call | |
| 16 | CELGENE CORP | 50,000 | 4,294,000 | 2.00% | Put | |
| 17 | ALKERMES PLC SHS | 85,000 | 4,278,000 | 2.00% | ||
| 18 | SUPERNUS PHARMACEUTICALS INC COM | 375,000 | 4,107,000 | 1.92% | ||
| 19 | Horizon Pharma Inc | 255,000 | 4,035,000 | 1.88% | ||
| 20 | TENET HEALTHCARE CORP | 85,000 | 3,990,000 | 1.86% | ||
| 21 | ALEXION PHARMACEUTIC | 25,000 | 3,906,000 | 1.82% | ||
| 22 | ACCELERON PHARMA | 110,000 | 3,737,000 | 1.74% | ||
| 23 | ST JUDE | 52,500 | 3,636,000 | 1.70% | ||
| 24 | AERIE PHARMACEUTICALS INC | 145,700 | 3,609,000 | 1.68% | ||
| 25 | CELLDEX THERAPEUTICS INC NEW | 210,000 | 3,427,000 | 1.60% | ||
| 26 | SALIX PHARMACEUTICALS INC | 27,500 | 3,392,000 | 1.58% | ||
| 27 | VERTEX PHARMACEUTICALS INC | 35,000 | 3,314,000 | 1.55% | Call | |
| 28 | LIGAND PHARMACEUTICALS INC | 50,000 | 3,115,000 | 1.45% | ||
| 29 | ENDOLOGIX INC | 195,000 | 2,966,000 | 1.38% | ||
| 30 | AMGEN INC | 25,000 | 2,959,000 | 1.38% | Call | |
| 31 | WRIGHT MEDICAL GROUP N.V. | 125,000 | 2,923,000 | 1.36% | ||
| 32 | SPECTRANETICS CORP | 125,000 | 2,860,000 | 1.33% | ||
| 33 | WRIGHT MEDICAL GROUP NV | 85,000 | 2,669,000 | 1.24% | ||
| 34 | TEVA PHARMACEUTICAL INDS LTD | 50,000 | 2,621,000 | 1.22% | ||
| 35 | CIGNA CORPORATION | 25,000 | 2,299,000 | 1.07% | ||
| 36 | IMPAX LABORATORIES INC | 75,000 | 2,249,000 | 1.05% | ||
| 37 | EDWARDS LIFESCIENCES CORP | 25,000 | 2,146,000 | 1.00% | Put | |
| 38 | ABBOTT LABS | 50,000 | 2,045,000 | 0.95% | Call | |
| 39 | BIOMARIN | 32,500 | 2,022,000 | 0.94% | ||
| 40 | Esperion Therapeutics Inc | 125,000 | 1,980,000 | 0.92% | ||
| 41 | NOVADAQ TECHNOLOGIES INC | 120,000 | 1,978,000 | 0.92% | ||
| 42 | ULTRAGENYX PHARMACEUTICAL INC COM | 41,800 | 1,876,000 | 0.88% | ||
| 43 | PUMA BIOTECHNOLOGY | 27,500 | 1,815,000 | 0.85% | ||
| 44 | DEPOMED INC | 125,000 | 1,738,000 | 0.81% | ||
| 45 | NPS Pharmaceuticals, Inc. | 52,500 | 1,736,000 | 0.81% | ||
| 46 | SUPERNUS PHARMACEUTICALS INC | 150,000 | 1,642,000 | 0.77% | Call | |
| 47 | VANDA PHARMACEUTICALS INC COM | 100,000 | 1,618,000 | 0.75% | ||
| 48 | LIGAND PHARMACEUTICALS INC | 25,000 | 1,557,000 | 0.73% | Put | |
| 49 | TESARO INC | 50,000 | 1,556,000 | 0.73% | ||
| 50 | IMPAX LABORATORIES INC | 50,000 | 1,500,000 | 0.70% | Put |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001597549-14-000004, filed 2014.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
